Oct 23 |
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio
|
Oct 23 |
Merck buys Modifi for $30M plus up to $1.3B in potential payments
|
Oct 23 |
Is Merck & Co., Inc. (NYSE:MRK) the Most Undervalued Value Stock to Buy According to Analysts?
|
Oct 23 |
Merck acquires cancer drug startup; Elevidys ex-US sales rise
|
Oct 22 |
Merck (MRK) Advances While Market Declines: Some Information for Investors
|
Oct 22 |
The Zacks Analyst Blog Highlights Visa, Netflix, Merck and Hovnanian
|
Oct 21 |
Top Research Reports for Visa, Netflix & Merck
|
Oct 21 |
Gilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks
|
Oct 20 |
Merck & Co. Inc. (MRK): Among the Best US Stocks for Foreign Investors Right Now
|
Oct 19 |
Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48
|